thymidine has been researched along with Blast Phase in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We cultured chronic myelogenous leukemia cells from the peripheral blood of several patients in blast crisis with three inhibitors of lipoxygenases: ETYA, and the more selective A63162 (Abbott) or SC41661A (Searle)." | 1.29 | Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase. ( Anderson, KM; Harris, JE; Jajeh, A; Levin, J; Seed, T, 1993) |
| " Control blasts exposed to increasing ara-C concentrations gave very similar dose-response curves; in striking contrast, blast cells cultured in hydrocortisone, then pulsed with ara-C did not lose colony-forming ability even though the same population was sensitive to 3HTdR." | 1.28 | Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside. ( McCulloch, EA; Minden, MD; Minkin, S; Wang, C; Yang, GS, 1991) |
| "Neoplastic cells of childhood acute lymphoblastic leukemia (ALL) with natural killer (NK) cell properties were studied for the expression of p75 interleukin-2 receptors (IL-2R) and the receptor functions." | 1.28 | Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties. ( Ichikawa, M; Kawai, H; Kinoshita, A; Komiyama, A; Miyasaka, M; Nakazawa, S; Tsudo, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gambacorti-Passerini, C | 1 |
| Zucchetti, M | 1 |
| Russo, D | 1 |
| Frapolli, R | 1 |
| Verga, M | 1 |
| Bungaro, S | 1 |
| Tornaghi, L | 1 |
| Rossi, F | 1 |
| Pioltelli, P | 1 |
| Pogliani, E | 1 |
| Alberti, D | 1 |
| Corneo, G | 1 |
| D'Incalci, M | 1 |
| Galimberti, S | 1 |
| Bianchi, F | 1 |
| Bernardini, N | 1 |
| Mattii, L | 1 |
| Dolfi, A | 1 |
| Lupetti, M | 1 |
| Petrini, M | 1 |
| Anderson, KM | 1 |
| Levin, J | 1 |
| Jajeh, A | 1 |
| Seed, T | 1 |
| Harris, JE | 1 |
| Usuki, K | 1 |
| Iki, S | 1 |
| Endo, M | 1 |
| Kitazume, K | 1 |
| Ito, K | 1 |
| Watanabe, M | 1 |
| Urabe, A | 1 |
| Szczylik, C | 1 |
| Skórski, T | 1 |
| Malaguarnera, L | 1 |
| Hetman, J | 1 |
| Chen, ST | 1 |
| Calabretta, B | 1 |
| Carter, A | 1 |
| Silvian-Draxler, I | 1 |
| Tatarsky, I | 1 |
| Yang, GS | 1 |
| Wang, C | 1 |
| Minkin, S | 1 |
| Minden, MD | 1 |
| McCulloch, EA | 1 |
| Ichikawa, M | 1 |
| Kawai, H | 1 |
| Komiyama, A | 1 |
| Tsudo, M | 1 |
| Miyasaka, M | 1 |
| Kinoshita, A | 1 |
| Nakazawa, S | 1 |
| Panella, TJ | 1 |
| Huang, AT | 1 |
| Pébusque, MJ | 1 |
| Lafage, M | 1 |
| Lopez, M | 1 |
| Mannoni, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label Randomized Clinical Trial to Compare the Toxicities and Efficacy of Pharmacokinetically-guided and BSA Fixed Dosing Strategy of Docetaxel and Paclitaxel in Chinese Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma, and Breast Cancer Patie[NCT01891123] | 300 participants (Anticipated) | Interventional | 2013-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for thymidine and Blast Phase
| Article | Year |
|---|---|
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzamides; Blast Crisis; Cell Division; Female; H | 2003 |
9 other studies available for thymidine and Blast Phase
| Article | Year |
|---|---|
Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
Topics: Acute Disease; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Breas | 1993 |
Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetamides; Amides; Apoptosis; Base Sequence; Blast Crisis; Blood C | 1993 |
Granulocyte colony-stimulating factor in acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Blast Crisis; Cell Division; Female; Granulocyte Colo | 1995 |
Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Topics: Antigens, CD34; beta 2-Microglobulin; Blast Crisis; Cell Division; DNA Primers; Down-Regulation; Hem | 1996 |
Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
Topics: Adolescent; Adult; Aged; Blast Crisis; Bone Marrow; Cell Division; DNA; Dose-Response Relationship, | 1992 |
Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Topics: Blast Crisis; Cell Survival; Cytarabine; DNA; Dose-Response Relationship, Drug; Doxorubicin; Humans; | 1991 |
Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties.
Topics: Adolescent; Antibodies, Monoclonal; Antigens, CD; Blast Crisis; Cell Division; Histocytochemistry; H | 1991 |
Effect of thimerosal in leukemia, in leukemic cell lines, and on normal hematopoiesis.
Topics: Antilymphocyte Serum; Blast Crisis; Cell Differentiation; Cell Line; DNA Replication; Ethylmercury C | 1990 |
Preferential response of acute myeloid leukemias with translocation involving chromosome 17 to human recombinant granulocyte colony-stimulating factor.
Topics: Animals; Blast Crisis; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line; Cell-Free System; Ch | 1988 |